Reactive oxygen species in cardiovascular disease

Free Radic Biol Med. 2011 Sep 1;51(5):978-92. doi: 10.1016/j.freeradbiomed.2011.05.004. Epub 2011 May 15.

Abstract

Based on the "free radical theory" of disease, researchers have been trying to elucidate the role of oxidative stress from free radicals in cardiovascular disease. Considerable data indicate that reactive oxygen species and oxidative stress are important features of cardiovascular diseases including atherosclerosis, hypertension, and congestive heart failure. However, blanket strategies with antioxidants to ameliorate cardiovascular disease have not generally yielded favorable results. However, our understanding of reactive oxygen species has evolved to the point at which we now realize these species have important roles in physiology as well as pathophysiology. Thus, it is overly simplistic to assume a general antioxidant strategy will yield specific effects on cardiovascular disease. Indeed, there are several sources of reactive oxygen species that are known to be active in the cardiovascular system. This review addresses our understanding of reactive oxygen species sources in cardiovascular disease and both animal and human data defining how reactive oxygen species contribute to physiology and pathology.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Antioxidants / therapeutic use
  • Biomarkers / metabolism*
  • Cardiovascular Diseases / drug therapy
  • Cardiovascular Diseases / metabolism*
  • Cardiovascular Diseases / physiopathology
  • Clinical Trials as Topic
  • Heart / drug effects
  • Heart / physiology*
  • Humans
  • Molecular Targeted Therapy / trends
  • Oxidative Stress* / drug effects
  • Reactive Oxygen Species / metabolism*

Substances

  • Antioxidants
  • Biomarkers
  • Reactive Oxygen Species